Nifty
:
23907.25
Sensex
:
79117.11
557.35 (2.39%)
1961.32 (2.54%)
Nifty
Sensex
:
:
23907.25
79117.11
557.35 (2.39%)
1961.32 (2.54%)

Windlas Biotech Ltd.

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 543329 | NSE: WINDLAS

NSE BSE
714.85
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  714.00
  •  719.50
  •  710.00
  •  710.75
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  15604
  •  111.47
  •  1198.25
  •  400.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,011.55
  • 31.40
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,995.26
  • 0.57%
  • 4.08

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 62.51%
  • 1.78%
  • 21.81%
  • FII
  • DII
  • Others
  • 2%
  • 7.57%
  • 4.33%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.32
  • 13.92
  • 10.64

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.78
  • 13.53
  • 8.32

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 26.41
  • 19.70
  • 15.17

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 18.27

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 2.01

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 10.45

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
187.00
152.67
22.49%
175.15
144.79
20.97%
171.28
140.71
21.73%
162.21
119.70
35.51%
Expenses
163.95
133.98
22.37%
154.27
127.64
20.86%
149.28
124.27
20.13%
141.88
105.75
34.17%
EBITDA
23.05
18.69
23.33%
20.88
17.14
21.82%
22.00
16.44
33.82%
20.34
13.95
45.81%
EBIDTM
12.33%
12.24%
11.92%
11.84%
12.85%
11.68%
12.54%
11.65%
Other Income
4.84
3.24
49.38%
4.13
2.62
57.63%
4.44
2.33
90.56%
3.16
2.16
46.30%
Interest
1.10
0.29
279.31%
0.49
0.24
104.17%
0.28
0.16
75.00%
0.31
0.16
93.75%
Depreciation
6.50
3.33
95.20%
6.21
3.19
94.67%
3.54
3.57
-0.84%
3.39
3.14
7.96%
PBT
20.29
18.31
10.81%
18.31
16.34
12.06%
22.63
15.04
50.47%
19.81
12.82
54.52%
Tax
4.63
4.28
8.18%
4.83
4.28
12.85%
5.64
3.60
56.67%
4.71
3.63
29.75%
PAT
15.66
14.03
11.62%
13.48
12.07
11.68%
16.99
11.44
48.51%
15.10
9.19
64.31%
PATM
8.37%
9.19%
7.70%
8.33%
9.92%
8.13%
9.31%
7.68%
EPS
7.49
6.75
10.96%
6.45
5.80
11.21%
8.17
5.47
49.36%
7.26
4.29
69.23%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Net Sales
695.64
630.96
513.08
465.93
427.60
328.85
307.27
352.20
Net Sales Growth
24.70%
22.97%
10.12%
8.96%
30.03%
7.02%
-12.76%
 
Cost Of Goods Sold
434.62
374.34
298.90
290.66
261.41
211.60
187.67
226.32
Gross Profit
261.02
256.61
214.18
175.27
166.20
117.26
119.59
125.88
GP Margin
37.52%
40.67%
41.74%
37.62%
38.87%
35.66%
38.92%
35.74%
Total Expenditure
609.38
552.78
452.86
413.51
372.91
287.39
268.76
312.87
Power & Fuel Cost
-
16.15
12.90
11.01
11.53
8.04
7.28
7.29
% Of Sales
-
2.56%
2.51%
2.36%
2.70%
2.44%
2.37%
2.07%
Employee Cost
-
87.46
70.32
63.41
58.32
43.57
42.96
44.54
% Of Sales
-
13.86%
13.71%
13.61%
13.64%
13.25%
13.98%
12.65%
Manufacturing Exp.
-
36.49
41.26
24.77
22.49
7.20
12.19
18.16
% Of Sales
-
5.78%
8.04%
5.32%
5.26%
2.19%
3.97%
5.16%
General & Admin Exp.
-
9.90
9.75
9.43
5.73
5.21
10.58
6.19
% Of Sales
-
1.57%
1.90%
2.02%
1.34%
1.58%
3.44%
1.76%
Selling & Distn. Exp.
-
22.11
14.60
10.68
8.39
8.79
5.32
6.16
% Of Sales
-
3.50%
2.85%
2.29%
1.96%
2.67%
1.73%
1.75%
Miscellaneous Exp.
-
6.34
5.12
3.54
5.04
2.98
2.76
4.20
% Of Sales
-
1.00%
1.00%
0.76%
1.18%
0.91%
0.90%
1.19%
EBITDA
86.27
78.18
60.22
52.42
54.69
41.46
38.51
39.33
EBITDA Margin
12.40%
12.39%
11.74%
11.25%
12.79%
12.61%
12.53%
11.17%
Other Income
16.57
13.47
9.96
6.71
3.09
2.49
4.26
4.21
Interest
2.18
1.10
0.79
1.42
1.29
2.53
4.84
6.47
Depreciation
19.64
13.44
12.36
12.15
12.96
9.29
10.59
17.35
PBT
81.04
77.09
57.04
45.56
43.53
32.13
27.34
19.73
Tax
19.81
18.90
14.41
7.48
6.17
8.46
12.29
8.65
Tax Rate
24.44%
24.52%
25.26%
16.42%
28.16%
26.33%
15.98%
43.84%
PAT
61.23
58.19
42.63
38.09
16.00
23.68
64.59
11.07
PAT before Minority Interest
61.23
58.19
42.63
38.09
15.74
23.68
64.59
11.07
Minority Interest
0.00
0.00
0.00
0.00
0.26
0.00
0.00
0.00
PAT Margin
8.80%
9.22%
8.31%
8.18%
3.74%
7.20%
21.02%
3.14%
PAT Growth
31.03%
36.50%
11.92%
138.06%
-32.43%
-63.34%
483.47%
 
EPS
29.30
27.84
20.40
18.22
7.66
11.33
30.90
5.30

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Shareholder's Funds
449.94
402.27
394.78
199.12
209.66
193.59
125.04
Share Capital
10.40
10.46
10.90
6.41
6.41
6.41
8.53
Total Reserves
434.65
388.99
382.07
192.71
203.25
187.17
116.51
Non-Current Liabilities
3.95
3.44
0.21
3.59
2.88
7.87
21.02
Secured Loans
0.00
0.11
0.44
0.83
1.21
5.82
18.14
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
2.32
2.02
1.57
1.37
1.19
1.06
1.46
Current Liabilities
171.75
121.24
93.99
93.42
125.29
96.22
143.09
Trade Payables
131.51
87.74
63.23
39.93
83.14
57.93
84.62
Other Current Liabilities
39.52
32.46
25.11
23.80
20.80
16.95
29.31
Short Term Borrowings
0.00
0.00
5.31
29.41
20.95
17.08
23.91
Short Term Provisions
0.73
1.04
0.33
0.28
0.41
4.25
5.26
Total Liabilities
625.64
526.95
488.98
296.13
337.83
297.68
289.15
Net Block
179.05
109.41
91.18
95.94
70.26
64.26
86.49
Gross Block
274.74
194.30
163.87
184.26
79.35
84.85
103.81
Accumulated Depreciation
95.69
84.89
72.69
88.32
9.09
20.59
17.32
Non Current Assets
194.35
173.41
107.32
101.81
169.80
177.21
145.19
Capital Work in Progress
5.71
14.78
8.01
0.04
0.00
4.58
52.56
Non Current Investment
0.00
0.00
0.00
0.00
94.00
101.45
0.19
Long Term Loans & Adv.
7.54
43.31
5.39
5.84
5.40
6.74
2.50
Other Non Current Assets
2.05
5.92
2.73
0.00
0.13
0.18
3.46
Current Assets
431.29
353.54
381.65
194.31
168.03
120.46
143.95
Current Investments
173.44
106.51
64.82
23.14
22.28
20.90
22.38
Inventories
62.19
74.74
58.71
41.46
49.32
19.03
35.05
Sundry Debtors
136.28
116.86
110.77
79.41
63.94
61.73
66.59
Cash & Bank
30.95
25.45
113.82
31.11
18.38
13.20
7.66
Other Current Assets
28.44
1.31
3.17
2.51
14.11
5.61
12.26
Short Term Loans & Adv.
26.79
28.66
30.36
16.67
13.65
5.28
11.74
Net Current Assets
259.54
232.29
287.67
100.89
42.74
24.24
0.86
Total Assets
625.64
526.95
488.97
296.12
337.83
297.67
289.14

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 18
Cash From Operating Activity
108.96
60.97
9.13
11.46
25.01
34.88
PBT
77.09
57.04
45.56
21.91
32.12
19.73
Adjustment
6.56
7.32
10.01
36.11
9.84
24.98
Changes in Working Capital
43.95
6.32
-37.57
-40.04
-3.53
-4.77
Cash after chg. in Working capital
127.61
70.68
18.01
17.99
38.43
39.94
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-18.65
-9.72
-8.88
-6.53
-13.43
-5.06
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-92.07
-14.11
-154.58
-20.20
-14.34
-10.99
Net Fixed Assets
-71.37
-37.20
12.42
-104.95
45.22
Net Investments
-66.90
-41.69
-41.68
103.80
-3.50
Others
46.20
64.78
-125.32
-19.05
-56.06
Cash from Financing Activity
-15.29
-43.74
130.09
0.78
-5.44
-26.05
Net Cash Inflow / Outflow
1.60
3.12
-15.36
-7.97
5.22
-2.16
Opening Cash & Equivalents
3.69
0.57
15.93
18.08
12.86
9.36
Closing Cash & Equivalent
5.29
3.69
0.57
15.93
18.08
7.20

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Book Value (Rs.)
213.99
190.89
180.31
109.36
327.03
301.96
218.50
ROA
10.10%
8.39%
9.70%
4.97%
7.45%
22.01%
3.83%
ROE
13.78%
10.76%
12.87%
7.70%
11.74%
40.92%
9.07%
ROCE
18.34%
14.39%
14.88%
9.93%
15.05%
40.49%
14.54%
Fixed Asset Turnover
2.69
2.87
2.68
3.24
4.01
3.26
3.39
Receivable days
73.22
80.97
74.49
61.18
69.74
76.22
68.98
Inventory Days
39.61
47.47
39.24
38.74
37.93
32.12
36.31
Payable days
106.89
92.18
64.78
85.92
86.12
98.41
95.45
Cash Conversion Cycle
5.93
36.25
48.95
14.00
21.55
9.93
9.84
Total Debt/Equity
0.00
0.00
0.02
0.16
0.13
0.15
0.44
Interest Cover
70.77
73.38
33.16
17.99
13.72
16.89
4.05

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015

News Update:


No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.